Breakthrough Discovery: Brain ‘Switch’ That Stops Hunger Could Revolutionize Obesity Treatment

An international team of researchers from Germany, Canada, and the UK has identified a remarkable mechanism in the brain that could transform how obesity is treated. The protein MRAP2 acts as a “switch,” signaling satiety to the brain and potentially forming the basis of revolutionary therapies.

This protein serves as a guide for the MC4R (melanocortin-4) receptor, a crucial regulator of appetite. MRAP2 ensures the receptor reaches the cell surface, where it can send stronger signals to the brain that the body is full. The MC4R receptor responds to the MSH (melanocortin) hormone, and genetic variants of this receptor are among the most common hereditary causes of severe obesity.

At the Collaborative Research Centre 1423 in Germany, scientists examined the three-dimensional structure of the active receptor and its interactions with ligands and drugs like setmelanotide, an approved medication that activates MC4R and reduces hunger in patients with specific genetic mutations.

Using advanced fluorescence microscopy and single-cell imaging, the team discovered that MRAP2 determines how MC4R is positioned within cells, affecting the body’s sense of satiety. This discovery provides new insight into the physiological control of appetite and could inspire therapies that mimic or regulate MRAP2 activity to combat obesity and related metabolic disorders.

According to Professors Annette Beck-Sickinger and Heike Biebermann, this international interdisciplinary collaboration has led to a deeper understanding of appetite regulation mechanisms, opening the door to innovative treatments that could “switch off” hunger directly in the brain.